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The correlates of indices of long-term ambulatory heart rate variability (HRV) of the auto-
nomic nervous system have not been completely understood. In this study, we evaluated
conventional HRV indices, obtained from the daytime (12:00–18:00) Holter recording, and a
recently proposed non-Gaussianity index (λ; Kiyono et al., 2008) in 12 patients withmultiple
system atrophy (MSA) and 10 patients with Parkinson disease (PD), known to have varying
degrees of cardiac vagal and sympathetic dysfunction. Compared with the age-matched
healthy control group, the MSA patients showed signiﬁcantly decreased HRV, most prob-
ably reﬂecting impaired vagal heart rate control, but the PD patients did not show such
reduced variability. In both MSA and PD patients, the low-to-high frequency (LF/HF) ratio
and the short-term fractal exponent α1, suggested to reﬂect the sympathovagal balance,
were signiﬁcantly decreased, as observed in congestive heart failure (CHF) patients with
sympathetic overdrive. In contrast, the analysis of the non-Gaussianity index λ showed that
a marked increase in intermittent and non-Gaussian HRV observed in the CHF patients was
not observed in the MSA and PD patients with sympathetic dysfunction. These ﬁndings
provide additional evidence for the relation between the non-Gaussian intermittency of
HRV and increased sympathetic activity.
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INTRODUCTION
The correlates of indices of long-term ambulatory heart rate vari-
ability (HRV) of the autonomic nervous system have not been
completely understood. In particular, there is yet no established
index for sympathetic activation, and most HRV indices proposed
primarily reﬂect reduced or impaired vagal function (Camm et al.,
1996; Marine et al., 2002; Bauer et al., 2006). Considering a key
role played by the sympathetic overdrive as one of the univer-
sal precipitating factors for various chronic illnesses (McEwen,
1998, 2007) and as a factor responsible for cardiac electrical insta-
bility (Schwartz et al., 1984), the quest for HRV indices probing
sympathetic activation would be of great importance.
As a marker potentially related to the sympathetic cardiac over-
drive, we have recently proposed increased non-Gaussianity of
HRV (Kiyono et al., 2008). This form of non-Gaussianity has
Abbreviations: AC, acceleration capacity; AMI, acute myocardial infarction; CHF,
congestive heart failure; DC, deceleration capacity; DFA, detrended ﬂuctuation
analysis; ECG, electrocardiogram; HF, high frequency; HRV, heart rate variabil-
ity; LF, low frequency; LF/HF, LF-to-HF ratio; MRI, magnetic resonance imaging;
MSA,multiple system atrophy;NN,normal-to-normal; PD,Parkinson disease; PDF,
probability density function; RMSSD, root mean square of successive difference of
NN intervals; SD, standard deviation; SDANN, standard deviation of 5min aver-
aged NN intervals; SDNN, standard deviation of all NN intervals; ULF, ultra-low
frequency; VLF, very low frequency.
been used in ﬂuid dynamics for characterizing intermittency
of turbulence (Castaing et al., 1990). When applied to HRV
analysis, it captures the occurrence of intermittent heart rate
increments (Kiyono et al., 2004, 2007). In a cohort of conges-
tive heart failure (CHF), Kiyono et al. (2008) initially observed
that the increased non-Gaussianity of HRV predicts increased
mortality risk, while none of the conventional HRV indices,
including those reﬂecting vagal heart rate control, were pre-
dictive of death among these patients. More recently, Hayano
et al. (2011) also reported that the increased non-Gaussianity
index, λ25s, which captures intermittent heart rate increments
within a scale of 25 s similar to that used in the study by Kiy-
ono et al. (2008), is associated with increased cardiac mortal-
ity risk in a cohort of acute myocardial infarction (AMI), with
the predictive power independent of other HRV indices. As
heart rate ﬂuctuations in the scale within a minute are medi-
ated almost exclusively by neural autonomic activities (Camm
et al., 1996), but λ25s showed no substantial correlation with
vagally mediated HRV indices and the patients taking β-blockers
had lower λ25s, Hayano et al. (2011) conjectured that the non-
Gaussianity index in this scale probably captures heart rate ﬂuc-
tuations mediated by intermittent activations of cardiac sympa-
thetic activity, affecting independently the mortality of cardiac
patients.
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In the present study, this conjecture is more directly tested by
studying long-term ambulatory HRV in patients with multiple
system atrophy (MSA). MSA is a sporadic and rapidly progres-
sive neurodegenerative disorder that presents with autonomic
failure in combination with Parkinsonism or cerebellar ataxia
(Wenning et al., 2008; Stefanova et al., 2009). The autonomic
symptoms are believed to be due to neuropathological abnormal-
ities in both preganglionic sympathetic (Sone et al., 2005) and
vagal (Benarroch et al., 2006) neurons. In previous HRV studies,
decreased high frequency, vagally mediated HRV was observed
in MSA patients than in age-matched healthy controls (Gure-
vich et al., 2004; Kuriyama et al., 2005), resembling the reduced
or impaired vagal function in cardiac patients (Camm et al.,
1996; Bauer et al., 2006). In contrast, because of degeneration
of the preganglionic sympathetic neurons, it is hypothesized that
the non-Gaussianity of HRV fails to markedly increase, such as
that observed in cardiac patients (Kiyono et al., 2008; Hayano
et al., 2011), in MSA patients. We test this hypothesis by com-
paring the results for MSA with those for CHF (Kiyono et al.,
2008); the results were reanalyzed in the same methodological
framework.
In the present study, we also studied ambulatory HRV in
patients with Parkinson disease (PD) in which autonomic fail-
ure is commonly observed (Lipp et al., 2009). As the autonomic
pathology of PD is different from that of MSA, being primarily
postganglionic as evidenced by decreased uptake of adrenergic
markers such as iodine-123 metaiodobenzylguanidine (Braune
et al., 1998, 1999), the degree, and balance of sympathetic and
vagal impairments could be different. Thus, it would be intriguing
to examine if the lack of increased non-Gaussianity is still observed
in PD.
MATERIALS AND METHODS
STUDY PATIENTS
Twelve MSA patients (six male and six female subjects; 61.9± 7.1,
54–76 years) and 10 patients with PD (two male and eight female
subjects; 71.1± 6.0, 63–81 years) at the Department of Neurol-
ogy of the University of Tokyo Hospital participated in this study
(Tables 1 and 2, respectively). Diagnosis was made according to
theUKParkinson’s Disease Society Brain BankClinical Diagnostic
Criteria (Hughes et al., 1992) and the second consensus state-
ment on MSA diagnosis (Gilman et al., 2008). All patients were
Table 1 | Clinical characteristics of multiple system atrophy (MSA) patients.
No Age (years) Sex Clinical diagnosis Symptoms at onset Illness duration (years) Ataxia Parkinsonism Autonomic failure
1 60 F MSA-C Instability of gait 4 ++ − +
2 64 M MSA-P Gait disturbance 1 − ++ +
3 61 M MSA-C Dysautonomia 3 ++ − +
4 57 M MSA-C Orthostatic symptoms 9 + − +
5 64 F MSA-C Instability of gait 3 ++ + +
6 54 M MSA-P Dysuria 4 − ++ +
7 75 F MSA-C Urinary urgency 4 ++ − +
8 56 F MSA-C Instability of gait 2 ++ − +
9 60 M MSA-C Dysarthria, gait disturbance 2 ++ ++ +
10 61 F MSA-C Gait disturbance 4 ++ ++ +
11 55 M MSA-P Instability of gait 2 ++ ++ +
12 76 F MSA-C Orthostatic symptoms 2 + +
MSA-C, MSA with predominant cerebellar ataxia; MSA-P, MSA with predominant Parkinsonism.
Table 2 | Clinical characteristics of patients with Parkinson disease.
No Age (years) Sex Clinical diagnosis Symptoms at onset Illness duration (years) Drug Hoehn–Yahr score
1 68 M PD Tremor 3 D, AC, DA III
2 63 M PD Hand tremor 21 D, M, DA IV
3 75 F PD Hand tremor, gait disturbance 11 D, DA, AM IV
4 66 F PD Gait disturbance, dysarthria 13 D, DA III
5 75 F PD Tremor, gait disturbance 31 D. DA. AM, AC IV
6 81 F PD Gait disturbance 5 D V
7 68 F PD Tremor 8 D, AC, AM, DA, M III
8 65 F PD HandTremor 8 D, DA III
9 72 F PD Gait disturbance 5 D, DA, AC, AM IV
10 78 F PD-D Gait disturbance, dysarthria 2 D III
PD, Parkinson disease; PD-D, PD with dementia; D, L-DOPA/carbidopa or benserazide; DA, dopamine agonists; A, anticholinergic; AM, amantadine; M, selegiline.
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examined by neurologists, and all PD patients exhibited a response
to L-DOPA without remarkable MRI ﬁndings. All MSA patients
fulﬁlled the criteria for probable MSA (Gilman et al., 2008), and
most of them took adrenergic stimulants for controlling severe
orthostatic hypotension and anti-adrenergic or anti-muscarinic
medications for their neurogenic bladder.
In addition, we studied 108 patients who were consecutively
referred for evaluationor treatment of CHF(61male and47 female
subjects; 66.1± 14.8, 21–92 years). Of these patients, 39 (36.1%)
died within the follow-up period of 33± 17months (range, 1–
59months). The medication status before discharge from the
hospital was not signiﬁcantly different between survivors and non-
survivors. The clinical details of the CHF patients were reported
previously (Kiyono et al., 2008).
The results were comparedwith data from age-matched healthy
subjects; the details of which were reported elsewhere (Kiyono
et al., 2004). All individuals within ±2 years of each patient’s age
were selected from a pool of 122 healthy subjects.
MEASUREMENTS AND PROTOCOL
The original electrocardiogram (ECG) data were derived from 24-
h Holter recordings. The ECG signals were digitized at 125Hz and
12 bits and processed ofﬂine using a personal computer equipped
with a dedicated software. All QRS complexes in each recording
were detected and labeled automatically. The results of automatic
analysis were reviewed, and any errors in Rwave classiﬁcationwere
corrected manually. Computer ﬁles were generated containing the
duration of individual R–R intervals and morphology classiﬁca-
tions of individual QRS complexes (normal, supraventricular, and
ventricular premature complexes). The series of intervals between
two successive R waves of sinus rhythm [normal-to-normal (NN)
intervals] was analyzed. To avoid the adverse effects of any remain-
ing errors in the detection of the Rwave, large (>20%) consecutive
R–R interval differences were thoroughly reviewed until all errors
were corrected. In addition, when atrial or ventricular prema-
ture complexeswere encountered, the correspondingR–R intervals
were interpolated by the median of the two successive beat-to-beat
intervals. We also conﬁrmed that no sustained tachyarrhythmias
were present in our HRV recordings. In this study, all HRV indices
were obtained from the daytime (12:00–18:00) data.
ANALYSIS OF CONVENTIONAL HRV INDICES
The following HRV indices were calculated: mean NN intervals,
standard deviation (SD) of all NN intervals (SDNN), SD of 5min
averaged NN intervals (SDANN), root mean square of successive
difference of NN intervals (RMSSD), the variances corresponding
to ultra-low frequency (ULF; 0–0.0033Hz), very low frequency
(VLF; 0.0033–0.04Hz), low frequency (LF; 0.04–0.15Hz), and
high frequency (HF; 0.15–0.40Hz) bands, and LF/HF ratio, all of
which were proposed by the Task Force of the European Society of
Cardiology and theNorthAmerican Society of Pacing andElectro-
physiology (Camm et al., 1996). The variances of these frequency
components were transformed to natural logarithmic values (ln
ms2).
In addition, we also computed the deceleration and acceler-
ation capacity (DC and AC) based on the phase rectiﬁed signal
averaging of NN intervals (Bauer et al., 2006), and the fractal
scaling exponents, the short-term exponent α1 and the long-term
α2, using detrended ﬂuctuation analysis (DFA; Peng et al., 1995).
MULTISCALE PROBABILITY DENSITY FUNCTION ANALYSIS
Recent studies from our group have shown that human HRV
exhibits the intermittent dynamics or temporal heterogeneity of
variance leading to non-Gaussian probability density function
(PDF) of heart rate increments (Kiyono et al., 2004), especially
in cardiac patients within timescales corresponding to LF andVLF
ranges (Kiyono et al., 2008; Hayano et al., 2011). As such a fea-
ture, called heteroscedasticity, cannot be captured by conventional
HRV indices, we conducted multiscale PDF analysis to character-
ize intermittent large deviations and the resultant non-Gaussianity
of HRV.
The procedure starts from interpolating observed series of NN
intervals with a cubic spline function and resampling at an interval
(Δt ) of 250ms (4Hz), yielding interpolated time series b(t ). Next
after subtracting average interval bave, integrated time series B(t )
are obtained by integrating b(t ) over the entire length,
B(t ) =
t/Δt∑
i=1
{b(iΔt ) − bave}.
As in previous studies (Kiyono et al., 2004, 2008; Hayano et al.,
2011), the local trend of B(t ) is eliminated by a third-order poly-
nomial ﬁt to B(t ) within moving windows of length 2s, where s
is the scale of analysis. Thereafter, intermittent deviation ΔsB(t )
is measured as the increment with a time lag s of the detrended
time series. For instance, in a window from time T− s to T + s,
the increments are calculated as follows:
ΔsB(t ) =
{
B(t + s/2) − fﬁt (t + s/2)
}
− {B(t − s/2) − fﬁt (t − s/2)
}
where T− s/2≤ t<T+ s/2 and fﬁt(t ) is the polynomial repre-
senting the local trend of B(t ). ΔsB(t ) reﬂects an average degree
of tachycardia if negative [b(t )< bave] or bradycardia if positive
[b(t )> bave] over a moving window with length s (in seconds)
after detrending. To quantitatively characterize the non-Gaussian
property of ΔsB(t ) at scale s, the standardized PDF (variance set
to one) constructed from allΔsB(t ) values is approximated by the
Castaing’s model (Castaing et al., 1990) with a single parameter
λs, which we refer to as the non-Gaussianity index. A greater λs
indicates a fatter non-Gaussian tail and a sharper peak of PDF
compared to the Gaussian distribution. On the other hand, if
λs is close to zero, PDF is close to a Gaussian distribution. The
parameter λs is estimated as follows:
λs
2 = 2
q(q − 2)
[
ln
(√
π
〈|ΔsB|q
〉)− lnΓ
(
q + 1
2
)
− q
2
ln 2
]
,
where q = 0 or 2, q> -1, and 〈|ΔsB|q〉 denotes the estimated
value of the q-th order absolute moment of ΔsB (Kiyono et al.,
2007).
In the present study, we calculated λs using the 0.25-th order
moment (q= 0.25) to emphasize the center part of PDF and
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reduce the effects of large outliers such as those resulting from
ectopic beats. This implies that our non-Gaussianity index with
q = 0.25 more strongly characterizes peak PDF around the center
of the observed non-Gaussian distribution, as opposed to higher-
order moments, such as kurtosis based on the fourth moment,
emphasizing heavy tails and extreme deviations. Based on our
recent ﬁndings that increased λs at scale s = 25 s is associated with
increased cardiac mortality risk and that this predictive power
is independent of clinical risk factors in CHF and AMI patients
(Kiyono et al., 2008; Hayano et al., 2011), we evaluated the non-
Gaussianity index λ25s at s = 25 s, which is at the edge of LF and
VLF ranges.
An important feature of this multiscale PDF analysis is that
if a time series has temporally homogeneous and ﬁnite variance,
the increment PDF of the integrated series rapidly converges to
a Gaussian distribution as the time-scale s increases because of
the well-known statistical law called the central limit theorem.
On the other hand, if neither condition is fulﬁlled, slow con-
vergence to a Gaussian distribution or a scale-dependent λs and
non-Gaussian fat tail can arise, suggestive of increased intermit-
tency as observed in hydrodynamic turbulence (Castaing et al.,
1990; Ghashghaie et al., 1996). Indeed, in the so-called multi-
plicative cascade model (Monin and Yaglom, 1975), one of the
representative models describing intermittency of hydrodynamic
turbulence and also used as a model of heart rate intermittency
(Lin and Hughson, 2001), λs is known to have scale dependence
in the form of λ2s ∼ ln s (Kiyono et al., 2007; Figure 1). In the
cascade model, multiscaling properties of the increments called
structure functions also exist in the corresponding scales (Kiyono
et al., 2007). To evaluate such a dynamic (cascade-like) aspect of
intermittent ﬂuctuations, we calculated the slope of λ2s vs. ln s
(λ2-slope) in the range 20< s< 200 s (mainly covering LF and
VLF ranges).
STATISTICAL ANALYSIS
The data are reported as the mean± SD. One-way ANOVA was
used to test for statistical differences across groups, and Tukey’s
honestly signiﬁcant difference test was used for pair-wise com-
parisons. For variables with skewed distributions, values were
transformed tonatural logarithms. TheKolmogorov–Smirnov test
was used to assess differences in age distribution between groups.
In addition, the bootstrap method (Efron and Tibshirani, 1993)
was used to assess possible selection biases of age-matched control
groups. Bootstrap samples having the same size as each of MSA
and PD groups were generated by randomly drawing age-matched
subjects with replacement fromapool of healthy subjects.P< 0.05
was considered signiﬁcant.
RESULTS
Indices of autonomic function were derived from HRV recordings
from MSA,PD, and CHF patients as well as from the three separate
age-matched control groups (MSA controls, 63.6± 8.6 years vs.
FIGURE 1 | Illustration of the definition of λ2-slope. (A) An example of
intermittent ﬂuctuation generated by a cascade model (Kiyono et al., 2007)
and (B) the scale dependence of λ2, which is proportional to the logarithmic
scale. To quantify this kind of intermittent behavior of HRV, λ2-slope is deﬁned
as the slope of a regression line between λ2 and the logarithmic scale in the
range between 20 and 200 s. (C) Scale dependence of λ2 for a patient with
multiple system atrophy (MSA) and a patient with congestive heart failure
(CHF).
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MSApatients,62.3± 7.4 years; PDcontrols,68.5± 8.3 years vs. PD
patients, 68.6± 7.9 years; CHF controls, 59.1± 16.0 years vs. CHF
patients, 66.1± 14.8 years). The age distributions for the control
groups were not signiﬁcantly different from those for the patients’
groups. Mean duration since MSA diagnosis was 3.3± 2.1 years
(range, 1–9 years; Table 1). Mean duration since PD diagnosis was
10.7± 9.1 years (range, 2–31 years), and themeanHoehn andYahr
score was 3.6± 0.7 (range, 3–5; Table 2).
CONVENTIONAL HRV INDICES
Table 3 presents HRV indices derived from HRV recordings from
MSA patients and age-matched healthy control subjects, together
with the bootstrap estimators for the healthy controls. Compared
with the control group, the MSA patients showed signiﬁcantly
decreasedHRVas indicated by lower SDNN,SDANN,andRMSSD
values, reduced power in all spectral bands (HF, LF,VLF,ULF), and
lower DC and AC. Indices such as LF/HF and DFA α1 were also
signiﬁcantly decreased. Compared with the control group, the PD
patients showed signiﬁcant decreases only in LF and VLF power
and signiﬁcantly lower DC and AC (Table 4). LF/HF and DFA
α1 were signiﬁcantly decreased. As shown in Tables 3 and 4, these
ﬁndings were largely supported also by comparingmean values for
the patient groups with 95%-conﬁdence intervals of the bootstrap
estimators. Table 5 presents the HRV indices in CHF patients and
age-matched healthy control subjects. Compared with the control
group, both surviving and non-surviving CHF patients exhibited
signiﬁcantly decreased HRV as indicated by lower SDNN and
SDANN, reduced power in LF, VLF, and ULF ranges, and lower
Table 3 | Heart rate variability measures in patients with multiple system atrophy (MSA) and age-matched controls.
MSA (n=12) Age-matched control (n=69) P value Bootstrap samples of age-matched control (n=12)
Mean NN, ms 766±89 775±110 0.745 776 (723–832)
SDNN, ms 59.7±23.0 90.4±28.6 <0.001 89.0 (75.4–104.2)
SDANN, ms 19.9±6.5 47.5±28.7 <0.001 48.8 (35.5–64.5)
RMSSD, ms 13.6±4.4 22.5±11.4 <0.001 21.6 (16.3–27.6)
ln HF, ln ms2 3.75±0.90 4.97±1.08 <0.001 4.93 (4.34–5.50)
ln LF, ln ms2 4.02±0.90 5.90±0.97 <0.001 5.90 (5.39–6.36)
ln VLF, ln ms2 5.92±0.84 7.26±0.81 <0.001 7.30 (6.89–7.72)
ln ULF, ln ms2 7.78±0.93 8.47±0.64 0.029 8.45 (8.14–8.79)
LF/HF ratio 1.69±1.24 3.28±2.49 0.002 3.47 (2.25–4.87)
DC, ms 3.38±0.98 6.23±1.59 <0.001 5.82 (5.11–6.53)
AC, ms −3.38±0.93 −6.51±1.77 <0.001 −6.13 (−6.94 to −5.28)
α1 0.86±0.24 1.17±0.15 <0.001 1.21 (1.08–1.33)
α2 1.23±0.09 1.18±0.04 0.118 1.19 (1.15–1.23)
λ25s 0.46±0.07 0.39±0.07 0.005 0.38 (0.35–0.43)
λ2-slope −0.05±0.12 −0.01±0.08 0.309 0.00 (−0.04 to 0.04)
Fifth column shows mean value and 95%-conﬁdence interval based on 2000 bootstrap samples. P<0.05.
Table 4 | Heart rate variability measures in patients with Parkinson disease and age-matched controls.
Parkinson disease (n=10) Age-matched control (n=60) P value Bootstrap samples of age-matched control (n=10)
Mean NN, ms 779±118 780±112 0.975 801 (717–885)
SDNN, ms 70.4±33.5 91.6±29.6 0.086 95.8 (76.1–118.7)
SDANN, ms 34.0±26.7 46.6±27.4 0.191 44.4 (30.3–62.2)
RMSSD, ms 18.2±11.6 23.1±12.8 0.240 26.3 (17.9–35.5)
ln HF, ln ms2 4.21±1.19 4.96±1.13 0.089 5.00 (4.30–5.71)
ln LF, ln ms2 4.22±1.31 5.70±0.97 0.006 5.69 (5.21–6.17)
ln VLF, ln ms2 5.82±1.20 7.17±0.82 0.006 7.13 (6.68–7.56)
ln ULF, ln ms2 8.15±0.77 8.55±0.64 0.148 8.66 (8.25–9.08)
LF/HF ratio 1.30±1.03 2.62±1.69 0.003 2.48 (1.60–3.54)
DC, ms 3.93±1.41 5.46±1.60 0.008 5.27 (4.45–6.11)
AC, ms −4.03±1.57 −5.80±1.81 0.007 −5.74 (−6.80 to −4.73)
α1 0.83±0.28 1.12±0.24 0.011 1.07 (0.96–1.19)
α2 1.17±0.08 1.19±0.07 0.456 1.18 (1.14–1.23)
λ25s 0.42±0.09 0.40±0.08 0.574 0.41 (0.37–0.46)
λ2-slope −0.01±0.11 −0.02±0.09 0.81 −0.02 (−0.06 to 0.03)
Fifth column shows mean value and 95%-conﬁdence interval based on 2000 bootstrap samples. P<0.05.
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Table 5 | Heart rate variability indices in patients with congestive heart failure and age-matched controls.
CHF (NS; n=39) CHF (SV; n=69) Control (n=90) P value NS–SV P value NS–C P value SV-C
Mean NN, ms 758±114 755±140 782±110 0.99 0.56 0.37
SDNN, ms 59.1±31.1 59.7±39.6 93.4±29.0 0.99 <0.001 <0.001
SDANN, ms 33.0±27.2 37.7±33.6 51.6±30.0 0.73 0.006 0.016
RMSSD, ms 37.6±40.0 40.0±48.3 24.5±12.8 0.94 0.13 0.017
ln HF, ln ms2 5.43±1.57 5.30±1.67 5.13±1.12 0.89 0.82 0.75
ln LF, ln ms2 4.97±1.80 4.85±1.63 5.97±1.01 0.90 0.001 <0.001
ln VLF, ln ms2 5.73±1.36 6.04±1.45 7.33±0.83 0.40 <0.001 <0.001
ln ULF, ln ms2 5.73±1.23 6.04±1.45 8.81±0.64 0.66 <0.001 <0.001
LF/HF ratio 0.83±0.79 0.93±0.78 3.01±2.31 0.95 <0.001 <0.001
DC, ms 3.39±1.60 3.84±2.01 5.87±1.70 0.43 <0.001 <0.001
AC, ms −4.34±2.29 −4.69±2.13 −6.27±1.96 0.68 <0.001 <0.001
α1 0.79±0.26 0.72±0.24 1.17±0.25 0.44 <0.001 <0.001
α2 0.93±0.16 1.00±0.21 1.18±0.08 0.048 <0.001 <0.001
λ25s 0.57±0.18 0.48±0.15 0.40±0.08 <0.001 <0.001 <0.001
λ2-slope −0.21±0.23 −0.13±0.18 −0.02±0.08 0.03 <0.001 <0.001
P<0.05.
DC and AC. Indices such as LF/HF, and DFA α1 and α2 were also
signiﬁcantly decreased.
In the MSA patients, the pattern of changes in conventional
HRV indices was similar to that observed in the CHF patients.
While the decreased HRV in both MSA and CHF patients might
reﬂect reduced vagal heart rate control, decreases in LF/HF and
DFA α1 were observed for both MSA, a disease with reported pre-
ganglionic sympathetic failure (Sone et al., 2005), and for CHF,
a pathology associated with sympathetic overdrive (Packer, 1988;
Ciarka et al., 2008). In contrast, no decreases in SDNN and HF
power, indices of reduced HRV, were observed in the PD patients,
which might reﬂect relatively intact vagal heart rate control. How-
ever, decreases in LF/HF and DFA α1 were also observed in PD, a
disease with reported postganglionic sympathetic failure (Braune
et al., 1998, 1999).
NON-GAUSSIAN AND INTERMITTENT PROPERTIES OF HRV
Figure 2 shows representative results of the multiscale PDF analy-
sis for MSA, CHF, and PD patients (one patient from each group)
and a healthy subject. As shown in Figures 2M–P, HRV data from
the MSA and PD patients and the healthy subject yielded similar
PDF curves at each scale. In contrast, recordings from the CHF
patient yielded a PDF curve with a more tapered center and fatter
tails at relatively smaller scales. This reﬂects intermittent largedevi-
ations or bursts observed at s = 20 s in CHF patients (Figure 2G),
while this increased intermittency was not observed in the MSA
and PD patients. In addition, as the scale s increases, deformation
of PDFs toward a Gaussian distribution was clearly observed only
in the CHF patient. The deformation process of the non-Gaussian
PDF can be described by the relation between the non-Gaussianity
indexλs and scale s. As shown in Figure 3, theMSA and PDpatient
groups and the healthy subject groups showed nearly constant λ2s
values across a wide range of scales s, resulting in an almost zero
value λ2-slope. In contrast, the CHF patient group, particularly
non-survivors, was characterized by almost linear increases in λ2s
as the log scale decreased from 200 to 20 s, similar to that observed
for a cascade model of intermittent turbulence (Figure 1B). Con-
sequently, theλ2-slope for theCHFpatientswas signiﬁcantlymore
negative than that for the healthy controls.
λ25s for the MSA patients was slightly but signiﬁcantly higher
than that for healthy controls (Table 3), although the level was
much lower than that for CHF non-survivors (Table 5). λ25s for
the PD patients failed to increase compared with that for healthy
controls (Table 4). Both MSA and PD patients with sympathetic
failure had λ2-slopes of almost zero, which were not signiﬁcantly
different from those of healthy controls (Tables 3 and 4). Only
CHF patients with known sympathetic overdrive had signiﬁcantly
negative λ2-slopes (Table 5).
DISCUSSION
Long-term ambulatory HRV continues to attract clinical interest
as a useful tool for risk stratiﬁcation in AMI (Kleiger et al., 1987;
Bigger et al., 1996; La Rovere et al., 1998; Schmidt et al., 1999;
Huikuri et al., 2000; Bauer et al., 2006) and chronic heart failure
(Ho et al., 1997;Nolan et al., 1998;Mäkikallio et al., 2001). Patients
at higher mortality risk frequently have higher heart rates with
reduced and less complex (or monotonic) HRV, and most indices
used to characterize such HRV dynamics primarily reﬂect reduced
or impaired vagal function (Camm et al., 1996; Marine et al., 2002;
Bauer et al., 2006). In contrast, few HRV indices are related to sym-
pathetic function and their autonomic correlates and prognostic
signiﬁcance are still uncertain. For example, a decrease, but not
the increase, in LF/HF, believed to reﬂect the sympathovagal bal-
ance (Pagani et al., 1986), is associated with increased mortality
risk (Tsuji et al., 1994; Huikuri et al., 2000) in patients exhibiting
sympathetic activation (Ciarka et al., 2008). Similarly, a decrease
in DFA α1, known to be correlated with LF/HF and sensitive
to changes in the sympathovagal balance (Huikuri et al., 2009),
is associated with increased mortality risk (Huikuri et al., 2000;
Mäkikallio et al., 2001). The present study further demonstrated
that both of these indices are also decreased inMSA,a neurodegen-
erative disorder associated with preganglionic sympathetic failure
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FIGURE 2 | Multiscale PDF characterization of heart rate variability.
Illustrative examples of time series of NN intervals b(t ) (A–D), time series of
Δ20sB(i ) (E–H), time series of Δ180sB(i ) (I–L), and standardized PDFs (in
logarithmic scale) of ΔsB(i ) for (from the top to bottom) s =20, 60, 180, 300 s
(M–P), where σs denotes the SD of ΔsB(i ). In solid lines, we superimpose the
PDF approximated by Castaing’s model (Castaing et al., 1990). The panels on
the leftmost side (A,E,I,M) are data for a 60-year-old male patient with
multiple system atrophy (MSA). The panels on the left-of-center side (B,F,J,N)
are data for a 68-year-old male patient with Parkinson disease (PD). The panels
on the right-of-center side (C,G,K,O) are data for a 83-year-old female patient
with congestive heart failure (CHF) who died 54 days after the measurement.
The panels on the rightmost side (D,H,L,P) are data for a control subject
(84-year-old male). For comparison, the dashed line denotes a Gaussian
distribution. Note that, while the raw b(t ) for the patients looks much different
from that for the control subject, the degrees of non-Gaussianity (i.e., the
shapes of PDF) remain unaltered across scales for MSA and PD patients and
the healthy control, except for those for the CHF patient at shorter scales
(G,O).
(Sone et al., 2005), and in PD, which is often accompanied by
postganglionic sympathetic failure (Braune et al., 1998, 1999).
As a marker potentially related to sympathetic cardiac over-
drive, we have recently introduced increased non-Gaussianity of
HRV within LF and VLF ranges in patients with CHF and AMI
(Kiyono et al., 2008;Hayano et al., 2011), cardiopathologies known
to be associated with sympathetic overdrive (Packer, 1988; Cia-
rka et al., 2008). In the present study, we further demonstrated
that a marked increase in intermittent and non-Gaussian HRV
was not observed in MSA and PD patients with sympathetic fail-
ure. We still have not determined why λ25s for the MSA patients
was slightly but signiﬁcantly higher than that for healthy controls;
this enhanced non-Gaussianity may be due to adrenergic stimu-
lants administered to ameliorate severe orthostatic symptoms in
the MSA patients. However, the scale-dependent increase in λ2s
with decreasing log scales mainly within the VLF range, leading
to a markedly higher λ25s in the CHF patients (Table 5), was not
observed in MSA. Therefore, we suggest that the systematically
increased non-Gaussianity of HRV within LF and VLF ranges
could be a hallmark of sympathetic cardiac overdrive and that
indices such as λ25s and λ2-slope could be used to measure the
degree of sympathetic activation. Indeed, we recently observed
decreased λ25s in the AMI patients taking (anti-sympathetic)
β-blockers (Hayano et al., 2011).
Using concepts developed in statistical and non-linear physics,
it has been demonstrated that the healthy human heart rate ﬂuctu-
ates in a complexmanner evenunder resting conditions, exhibiting
fractal long-range correlations (Peng et al., 1993; Yamamoto and
Hughson, 1994) and multifractal properties (Ivanov et al., 1999;
Amaral et al., 2001; Ching and Tsang, 2007). Based on these
ﬁndings, Lin and Hughson (2001) proposed an analogy between
heart rate dynamics and hydrodynamic turbulence because a
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FIGURE 3 |Time-scale dependence of the non-Gaussianity index, λ2.The
results for (A) multiple system atrophy (MSA), (B) Parkinson disease (PD),
and (C) congestive heart failure (CHF) patients, both for survivor (SV; n =69)
and non-survivor (NS; n =39). Age-matched controls were selected from a
database of healthy subjects. Error bars indicate 95%-conﬁdence intervals of
the group averages.
phenomenological model of hydrodynamic turbulence, called the
multiplicative cascade model (Monin and Yaglom, 1975), can also
have multifractal properties. Using multiscale PDF analysis, we
later demonstrated that the healthy human HRV does not show
slow and gradual convergence to a Gaussian distribution (Kiyono
et al., 2004;Figure 3), an important requirement of themultiplica-
tive cascade model (Figure 1B). In contrast, the present study and
previous work (Kiyono et al., 2008) suggest that HRV within LF
andVLF ranges of CHF patients, especially non-survivors, is more
compatible with the multiplicative cascade model.
The multiplicative (log-normal) cascade model used to gener-
ate ﬂuctuations with intermittent bursts such as those shown in
Figure 1A is given by
xi = ξi exp
⎡
⎣
m∑
j=1
ω(j)
(⌊
j − 1
2m−j
⌋)⎤
⎦ ,
where ξi is Gaussian white noise with zero mean,ω(j)(k) are inde-
pendent Gaussian random variables with zero mean and constant
variance, and (·( is the ﬂoor function (Kiyono et al., 2007). The m
is the total number of cascade steps, yielding the total number of
data points 2m (i= 1, . . ., 2m). An essential part of themodel is that
ξi ismodulated bymultiplication of random (log-normal) weights
exp[ω(j)(k)] (k = 0, 1, . . ., 2j − 1) at the j-th step every 2m−j
subintervals; therefore, large ﬂuctuations are observed only when
the momentary weights for (many) different steps with varying
timescales are simultaneously large (refer to Figure 5 of Kiyono
et al., 2007). Using multiscale PDF analysis, Kiyono et al. (2007)
further showed that this model exhibits the scale dependence of a
non-Gaussianity index in the form of λ2s ∼ ln s (Figure 1B).
The fact that heart rate dynamics of CHF patients with sym-
pathetic activation exhibit a non-Gaussianity index which decays
with scales within LF and VLF ranges suggests a sympathetic ori-
gin for HRV intermittency. In these scales (20–200 s), heart rate
dynamics reﬂect cardiovascular regulation by neural, humoral,
and thermal inﬂuences (Kitney and Rompelman, 1980). These
subsystems are considered to be compensatory; therefore, it is
likely that only simultaneous failure of all these subsystems oper-
ating at multiple timescales, compatible with the reciprocal of
cascade steps “j” in the above example, could result in sympathetic
overdrive, leading to large and intermittent heart rate deviations.
We propose that such a multiplicative picture would provide a
deeper physiological understanding of the nature of sympathetic
function. In addition, it would provide a reason why methods
requiring stationary, not intermittent, dynamics have not been
successful in ﬁnding the sympathetic correlates of ambulatory
HRV.
In the present study,we focused ondaytimeHRV for the follow-
ing reasons. First, as reported in our previous study (Kiyono et al.,
2005), there are large differences in non-Gaussianity and its scale
dependencebetweenday andnight inhealthyhumans,presumably
because of the difference in the sympathovagal balance. Second,
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disorders of sleep and sleep breathing are common in MSA
(Colosimo, 2011); therefore, incorporating nighttime data would
inevitably introduce additional complexity. Third,one of our goals
is to assess sympathetic activity, which is predominant during the
day. Note that this shift from 24-h HRV to daytime HRV does
not change our previous ﬁnding of the increased non-Gaussianity
of low frequency HRV in CHF patients than in healthy controls
(Kiyono et al., 2008).
In agreement with previous studies (Gurevich et al., 2004;
Kuriyama et al., 2005), our MSA patients showed signiﬁcantly
decreased HRV, as evidenced by lower SDNN and HF power. This
decrease is probably related to the known abnormalities in cen-
tral vagal (Benarroch et al., 2006) and sympathetic function in
these patients (Sone et al., 2005). On the other hand, changes in
SDNN and HF power were not signiﬁcant in PD patients, imply-
ing relatively intact vagal heart rate control despite the impaired
peripheral, cardiac sympathetic function (Braune et al., 1998,
1999). Thus, analyses of ambulatory HRV may facilitate discrim-
inative diagnosis between MSA and PD, particularly the difﬁcult
distinction between early stage PD and MSA with predominant
Parkinsonian symptoms (Lipp et al., 2009).
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